Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2023 Jun 19;15(6):1769.
doi: 10.3390/pharmaceutics15061769.

Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15, 682

Aleksandr Kazimir  1 , Benedikt Schwarze  2 , Peter Lönnecke  1 , Sanja Jelača  3 , Sanja Mijatović  3 , Danijela Maksimović-Ivanić  3 , Evamarie Hey-Hawkins  1
Affiliations
Published Erratum

Correction: Kazimir et al. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023, 15, 682

Aleksandr Kazimir et al. Pharmaceutics. .

Abstract

In the original publication [...].

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Incorporation of the nido-carborate dianion in 2,2′-bipyridine complexes: (A) initial formation of metallacarboranes (not shown) followed by reaction with ligand 4; (B) initial formation of metal(II) dichloride complexes 5 and 6 followed by reaction with Tl [closo-TlC2B9H11] for chloride replacement.
See this image and copyright information in PMC

Erratum for

References

    1. Kazimir A., Schwarze B., Lönnecke P., Jelača S., Mijatović S., Maksimović-Ivanić D., Hey-Hawkins E. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics. 2023;15:682. doi: 10.3390/pharmaceutics15020682. - DOI - PMC - PubMed

Publication types

LinkOut - more resources